Cited by 343Fatty Acid Research and HealthTryptophan and brain disordersNutritional Studies and Diet

Omega-3 supplementation lowers inflammation and anxiety in medical students: A randomized controlled trial

Open access
Kiecolt-Glaser, Janice K., Belury, Martha A., Andridge, Rebecca, Malarkey, William B., Glaser, Ronald·2011·Brain, Behavior, and Immunity

Abstract

Observational studies have linked lower omega-3 (n-3) polyunsaturated fatty acids (PUFAs) and higher omega-6 (n-6) PUFAs with inflammation and depression, but randomized controlled trial (RCT) data have been mixed. To determine whether n-3 decreases proinflammatory cytokine production and depressive and anxiety symptoms in healthy young adults, this parallel group, placebo-controlled, double-blind 12-week RCT compared n-3 supplementation with placebo. The participants, 68 medical students, provided serial blood samples during lower-stress periods as well as on days before an exam. The students received either n-3 (2.5 g/d, 2085 mg eicosapentaenoic acid and 348 mg docosahexanoic acid) or placebo capsules that mirrored the proportions of fatty acids in the typical American diet. Compared to controls, those students who received n-3 showed a 14% decrease in lipopolysaccharide (LPS) stimulated interleukin 6 (IL-6) production and a 20% reduction in anxiety symptoms, without significant change in depressive symptoms. Individuals differ in absorption and metabolism of n-3 PUFA supplements, as well as in adherence; accordingly, planned secondary analyses that used the plasma n-6:n-3 ratio in place of treatment group showed that decreasing n-6:n-3 ratios led to lower anxiety and reductions in stimulated IL-6 and tumor necrosis factor alpha (TNF-α) production, as well as marginal differences in serum TNF-α. These data suggest that n-3 supplementation can reduce inflammation and anxiety even among healthy young adults. The reduction in anxiety symptoms associated with n-3 supplementation provides the first evidence that n-3 may have potential anxiolytic benefits for individuals without an anxiety disorder diagnosis. ClinicalTrials.gov identifier: NCT00519779.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbi.2011.07.229

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In that study, omega-3 supplementation was unrelated to changes in depression.

    “Although omega-3 supplementation was unrelated to changes in depression in this study”

    From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as Kiecolt-Glaser, Belury, Andridge, Malarkey, & Glaser, 2011

  • In a double-blind, randomized, placebo-controlled trial, medical students who received omega-3 supplementation exhibited a 14% reduction in LPS-stimulated IL-6 production and a 20% reduction in anxiety symptoms compared to control.

    “medical students who received omega-3 supplementation exhibited a 14% reduction in LPS-stimulated IL-6 production and a 20% reduction in anxiety symptoms compared to those in the control group”

    From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as Kiecolt-Glaser, Belury, Andridge, Malarkey, & Glaser, 2011

  • Randomized controlled trials have shown that omega-3 fatty acid supplementation lowers inflammation and may have health-promoting effects.

    “various RCTs have shown that omega-3 fatty acid supplementation reduces inflammation142–144 and may thus have health-promoting effects141–144”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 70 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Kiecolt-Glaser, J. K., Belury, M. A., Andridge, R., Malarkey, W. B., & Glaser, R.
Affiliations
The Ohio State University (US)
Venue
Brain, Behavior, and Immunity
Publisher
Elsevier BV
Published
2011-11
Volume
25
Issue
8
Pages
1725-1734
ISSN
0889-1591 (ISSN-L)
OpenAlex
W2140758044
Cited by
340
References
70
Citations by year
2026: 19 · 2025: 18 · 2024: 30 · 2023: 24 · 2022: 31 · 2021: 32 · 2020: 24 · 2019: 28 · 2018: 18 · 2017: 21 · 2016: 13 · 2015: 24 · 2014: 26 · 2013: 15 · 2012: 17
FWCI
17.14
Type
journal article
Language
en
Open access
Locations
  • Brain Behavior and Immunity (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Ohio State University
  • National Institutes of Health (UL1TR000090)
  • National Cancer Institute (CA16058, P30CA016058)
  • National Center for Complementary and Alternative Medicine
  • National Center for Research Resources (UL1RR025755)
  • NIH Clinical Center
  • National Center for Advancing Translational Sciences
  • National Center for Complementary and Integrative Health (R21AT003912, AT003912)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
Keywords
omega-3 fatty acids, n-6/n-3 ratio, inflammation, anxiety, depression, medical students, eicosapentaenoic acid, docosahexaenoic acid, interleukin-6, TNF-α, lipopolysaccharide stimulation, exam stress, young adults
MeSH terms
Adult, Affect, Anxiety, Depression, Diet, Double-Blind Method, Fatty Acids, Female, Humans, Inflammation, Male, Neutrophils, Patient Compliance, Stress, Psychological, Health Behavior, Exercise, Fatty Acids, Omega-3, Cytokines, Sample Size, Dietary Supplements, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review